Progress in research into the role of abnormal glycosylation modification in tumor immunity
- 10 November 2020
- journal article
- review article
- Published by Elsevier BV in Immunology Letters
- Vol. 229, 8-17
- https://doi.org/10.1016/j.imlet.2020.11.003
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 116 references indexed in Scilit:
- An IKKα–E2F1–BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrenceJournal of Bone and Joint Surgery, 2013
- Complexities of TGF-β Targeted Cancer TherapyInternational Journal of Biological Sciences, 2012
- The Plasticity of Regulatory T Cell FunctionThe Journal of Immunology, 2011
- Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4Science, 2011
- Camouflage and sabotage: tumor escape from the immune systemCancer Immunology, Immunotherapy, 2011
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- B-cell-derived lymphotoxin promotes castration-resistant prostate cancerNature, 2010
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- Structural and Mechanistic Features of Protein O Glycosylation Linked to CD8+ T-Cell ApoptosisMolecular and Cellular Biology, 2007
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002